5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

NCT00120523 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2418

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Pimecrolimus
DRUG: Topical corticosteroids

Sponsor

MEDA Pharma GmbH & Co. KG